(Q35573139)

8 August 2017

Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients (English)

1 reference

8 August 2017

Pseudomonas aeruginosa

0 references

1 reference

Al-Aloul M

1

1 reference

8 August 2017

Crawley J

2

1 reference

8 August 2017

Winstanley C

3

1 reference

8 August 2017

Hart CA

4

1 reference

8 August 2017

Ledson MJ

5

1 reference

8 August 2017

Walshaw MJ

6

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

8 August 2017

1 reference

8 August 2017

59

1 reference

8 August 2017

334-336

1 reference

8 August 2017

4

1 reference

Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763796

Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763796

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763796

Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763796

Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763796

Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763796

Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763796

Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763796

Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15047956

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15047956

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15047956

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THX.2003.014258

1 reference

8 August 2017

1 reference

8 August 2017

1 reference